Herpes Treatment Options: Beyond the Stigma | Wiki Coffee

Herpes treatment options have evolved significantly since the introduction of acyclovir in the 1980s, with valacyclovir and famciclovir emerging as key players in the antiviral market. However, the lack of a cure and the ongoing stigma surrounding herpes simplex virus (HSV) infections have driven the demand for alternative therapies, including herbal supplements and immunotherapy. According to a study published in the New England Journal of Medicine, approximately 67% of the global population under the age of 50 is infected with HSV-1, highlighting the need for effective treatment and prevention strategies. The development of gene-editing technologies like CRISPR has also sparked interest in potential curative approaches, with companies like Editas Medicine and CRISPR Therapeutics leading the charge. Despite these advancements, controversy surrounds the use of off-label medications and the role of big pharma in shaping the treatment landscape. As researchers continue to explore new avenues, the herpes treatment landscape is poised to undergo significant changes, with a potential market size of $13.4 billion by 2025, according to a report by Grand View Research.